Department of Nuclear Medicine, The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.
Department of Nuclear Medicine, The First People's Hospital of Yunnan Province, Kunming, China.
Front Endocrinol (Lausanne). 2022 Sep 8;13:915279. doi: 10.3389/fendo.2022.915279. eCollection 2022.
To explore the valuably influential factors and improve the diagnostic accuracy and efficiency of Tc-methoxyisobutylisonitrile (MIBI) uptake in parathyroids of secondary hyperparathyroidism (SHPT) patients with chronic renal failure (CRF).
The correlation analysis was performed between clinical indices related to CRF and Tc-MIBI uptake intensity TBR (the gray value mean ratio between the parathyroid target and the bilateral neck background, semiquantitatively calculated with ImageJ software). All clinical indices and TBRs were compared by a three- or two-level grouping method of MIBI uptake, which was visually qualitatively assessed. The three-level grouping method comprised slight, medium, and high groups with little, faint, and distinct MIBI concentration in parathyroids, respectively. The two-level grouping method comprised insignificant and significant groups with TBR greater than or less than 0.49-0.71, respectively.
MIBI uptake was significantly positively related to patient age, CRF course, hemodialysis vintage, serum parathyroid hormone (PTH), and alkaline phosphatase (AKP) but was significantly negatively related to serum uric acid (UA). MIBI washout was significantly positively related to patient age but was significantly negatively related to serum phosphorus (P) and calcium (Ca) × P. Oral administration of calcitriol and calcium could significantly reduce the MIBI uptake. MIBI uptake tendency might alter. Such seven indices, namely the MIBI uptake, CRF course, hemodialysis vintage, serum AKP, calcium, cysteine proteinase inhibitor C, and PTH, were comparable between the slight and medium groups but were significantly different between the slight and high groups or between the medium and high groups. The above seven indices plus blood urea nitrogen/creatinine were all significantly different between the insignificant and significant groups. All above significances were with < 0.05.
Patient age, CRF course, hemodialysis vintage, serum PTH, AKP, UA, phosphorus, Ca × P, oral administration of calcitriol and calcium, and parathyroids themselves can significantly influence MIBI uptake in parathyroids of SHPT patients with CRF. The two-level grouping method of MIBI intensity should be adopted to qualitatively diagnose the MIBI uptake.
探讨影响慢性肾衰竭继发甲状旁腺功能亢进症(SHPT)患者甲状旁腺锝-甲氧基异丁基异腈(MIBI)摄取的有价值的影响因素,提高其诊断的准确性和效率。
采用图像分析软件(ImageJ)半定量计算甲状旁腺靶与双侧颈部背景的灰度值均值比值(TBR),对与慢性肾衰竭相关的临床指标与 MIBI 摄取强度 TBR 进行相关性分析。根据 MIBI 摄取的视觉定性评估,采用三级或两级分组方法对所有临床指标和 TBR 进行比较,将 MIBI 摄取分为轻度、中度和重度组,甲状旁腺内 MIBI 浓度分别为少量、微弱和明显;将 TBR 大于或小于 0.49-0.71 分为无意义组和有意义组。
MIBI 摄取与患者年龄、慢性肾衰竭病程、血液透析龄、血清甲状旁腺激素(PTH)和碱性磷酸酶(AKP)呈显著正相关,与血清尿酸(UA)呈显著负相关。MIBI 洗脱与患者年龄呈显著正相关,与血清磷(P)和钙(Ca)×P 呈显著负相关。口服骨化三醇和钙可显著降低 MIBI 摄取。MIBI 摄取倾向可能会改变。MIBI 摄取、慢性肾衰竭病程、血液透析龄、血清 AKP、钙、半胱氨酸蛋白酶抑制剂 C 和 PTH 等 7 项指标在轻度和中度组之间无差异,但在轻度和重度组或中度和重度组之间有差异。上述 7 项指标加上血尿素氮/肌酐在无意义组和有意义组之间均有差异。以上所有差异均具有统计学意义(均 < 0.05)。
患者年龄、慢性肾衰竭病程、血液透析龄、血清 PTH、AKP、UA、P、Ca×P、口服骨化三醇和钙以及甲状旁腺本身均可显著影响慢性肾衰竭继发甲状旁腺功能亢进症患者甲状旁腺 MIBI 的摄取。应采用 MIBI 强度的两级分组方法对 MIBI 摄取进行定性诊断。